0
Your cart

Your cart is empty

Browse All Departments
  • All Departments
Price
  • R2,500 - R5,000 (1)
  • R5,000 - R10,000 (1)
  • -
Status
Brand

Showing 1 - 2 of 2 matches in All Departments

Erythrocytes as Drug Carriers in Medicine (Hardcover, 1997 ed.): Ulrich Sprandel, James L. Way Erythrocytes as Drug Carriers in Medicine (Hardcover, 1997 ed.)
Ulrich Sprandel, James L. Way
R5,377 Discovery Miles 53 770 Ships in 7 - 11 working days

The sixth meeting on the use of resealed annealed red blood cells was held in Irsee, Germany by the International Society for the Use of Resealed Erythrocytes (ISURE) on July 25-28, 1996. Although earlier meetings focused on the technology toward develop ment of methods and standardization for efficient, consistent encapsulation, most of the present studies now are directed toward the application use of these carrier blood cells. Basic studies now have been directed toward exploration of commercial applications. In deed, clinical trials were initiated to evaluate the dose-response curves employing L asparagenase in human patients. Also, studies have shown the use of thrombolytic agent in erythrocyte carriers with the use of human red blood cells to provide a new conceptual ap proach in thrombolytic therapy to prevent thrombosis in individuals with higher risk fac tors. For example, with the use of carrier red blood cells, the thrombolytic agents will have a greater potential of acting on clot formation without systemic activation and thus lower the risk of hemorrhage, which is always prevalent in the thrombolytic therapy."

Erythrocytes as Drug Carriers in Medicine (Paperback, Softcover reprint of the original 1st ed. 1997): Ulrich Sprandel, James... Erythrocytes as Drug Carriers in Medicine (Paperback, Softcover reprint of the original 1st ed. 1997)
Ulrich Sprandel, James L. Way
R3,394 Discovery Miles 33 940 Ships in 7 - 11 working days

The sixth meeting on the use of resealed annealed red blood cells was held in Irsee, Germany by the International Society for the Use of Resealed Erythrocytes (ISURE) on July 25-28, 1996. Although earlier meetings focused on the technology toward develop ment of methods and standardization for efficient, consistent encapsulation, most of the present studies now are directed toward the application use of these carrier blood cells. Basic studies now have been directed toward exploration of commercial applications. In deed, clinical trials were initiated to evaluate the dose-response curves employing L asparagenase in human patients. Also, studies have shown the use of thrombolytic agent in erythrocyte carriers with the use of human red blood cells to provide a new conceptual ap proach in thrombolytic therapy to prevent thrombosis in individuals with higher risk fac tors. For example, with the use of carrier red blood cells, the thrombolytic agents will have a greater potential of acting on clot formation without systemic activation and thus lower the risk of hemorrhage, which is always prevalent in the thrombolytic therapy."

Free Delivery
Pinterest Twitter Facebook Google+
You may like...
Scatterling Of Africa - My Early Years
Johnny Clegg Paperback  (1)
R360 R260 Discovery Miles 2 600
Bostik Crystal Clear Tape on Dispenser…
R33 R24 Discovery Miles 240
Swiss Mobile Gear Gellihug Switch Shell…
 (3)
R199 Discovery Miles 1 990
Watchmen
Regina King, Don Johnson, … DVD R200 Discovery Miles 2 000
Beautiful Trauma
Pink CD  (3)
R280 Discovery Miles 2 800
Elektra Health 8076 Electrode Hot Steam…
 (13)
R429 Discovery Miles 4 290
Handover Foam Brush (2")(5cm)
R19 R14 Discovery Miles 140
Loot
Nadine Gordimer Paperback  (2)
R335 R286 Discovery Miles 2 860
Kinnov F9 Dynamite IPX6 Waterproof…
R1,699 R899 Discovery Miles 8 990
Green Book
Viggo Mortensen, Mahershala Ali, … Blu-ray disc  (1)
R198 Discovery Miles 1 980

 

Partners